HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Changing response to diamidine compounds in cases of kala-azar unresponsive to antimonial.

Abstract
Two hundred and forty patients of kala-azar unresponsive to antimonial were treated with pentamidines in a dose of 4 mg/kg body weight on alternate days for 20 injections. Of these, 175 were treated with pentamidine isethionate and 65 with pentamidine methane sulphonate (Lomidine). Clinical and parasitological cure were significantly higher with lomidine as compared to pentamidine isethionate. However, cardiovascular, gastrointestinal and metabolic toxicity including hyperglycaemia were more marked with lomidine. Mortality rate was also significantly (P less than .05) higher with lomidine therapy. Significantly lower clinical and parasitological cure and higher relapse rate were observed in the present study compared with an earlier study in which pentamidine was used in the same doses for 10-12 injections only.
AuthorsS N Jha, N K Singh, T K Jha
JournalThe Journal of the Association of Physicians of India (J Assoc Physicians India) Vol. 39 Issue 4 Pg. 314-6 (Apr 1991) ISSN: 0004-5772 [Print] India
PMID1938817 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Pentamidine
Topics
  • Adult
  • Drug Evaluation
  • Female
  • Follow-Up Studies
  • Humans
  • Leishmaniasis, Visceral (drug therapy)
  • Male
  • Pentamidine (administration & dosage, adverse effects, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: